Addyi Radio Ad’s Lack Of Alcohol Risk Information Elicits New Clash With US FDA

Agency directs Sprout to disseminate corrective messages about the risks associated with the female sexual dysfunction pill. Sprout previously challenged FDA’s alcohol labeling requirements.

f100
FDA objects to radio ad for Sprout's hypoactive sexual desire disorder drug Addyi • Source: Shutterstock

More from Marketing & Advertising

More from Compliance